PRANLUKASTHEMIHYDRATE;8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-benzamide hemihydrate;Pranlukast hemihydrate >=98% (HPLC), white solid;Benzamide,N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-,hydrate (2:1);N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phe...;Pranlukast hydrateQ: What is
Pranlukast hydrate Q: What is the CAS Number of
Pranlukast hydrate Q: What is the storage condition of
Pranlukast hydrate;N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide,hydrate
H413：May cause long lasting harmful effects to aquatic life
Precautionary statements
P273：Avoid release to the environment.
P302+P352：IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338：IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
Description
A subtype specific CysLT1 receptor antagonist. Leukotrienes are involved in the inflammation response and are divided into two main classes leukotriene B4 and cysteinyl-substituted leukotrienes.
![8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran](https://www.chemicalbook.com/CAS/GIF/150821-03-7.gif)
